Connecting data, tools and people across Europe: ELIXIR’s response to the COVID-19 pandemic
暂无分享,去创建一个
[1] G. Gibson. Going to the negative: genomics for optimized medical prescription , 2018, Nature Reviews Genetics.
[2] Piers Millett,et al. Developing Global Norms for Sharing Data and Results during Public Health Emergencies , 2016, PLoS medicine.
[3] Pardis C. Sabeti,et al. Data sharing: Make outbreak research open access , 2015, Nature.
[4] F. Sanz,et al. Towards a European health research and innovation cloud (HRIC) , 2020, Genome Medicine.
[5] D. Carr,et al. Sharing Research Data to Improve Public Health , 2015, Journal of empirical research on human research ethics : JERHRE.
[6] Sumiko Mekaru,et al. Open access epidemiological data from the COVID-19 outbreak , 2020, The Lancet Infectious Diseases.
[7] Sophie Delaunay,et al. Knowledge sharing during public health emergencies: from global call to effective implementation , 2016, Bulletin of the World Health Organization.
[8] John Chilton,et al. No more business as usual: Agile and effective responses to emerging pathogen threats require open data and open analytics , 2020, PLoS pathogens.
[9] C. Rivers,et al. Make Data Sharing Routine to Prepare for Public Health Emergencies , 2016, PLoS medicine.
[10] D. Mietchen. Data sharing in public health emergencies , 2016 .
[11] Rolf Apweiler,et al. The European Bioinformatics Institute in 2017: data coordination and integration , 2017, Nucleic Acids Res..
[12] Özlem Tastan Bishop,et al. H3ABioNet, a sustainable pan-African bioinformatics network for human heredity and health in Africa , 2016, Genome research.
[13] Arcadi Navarro,et al. Leveraging European infrastructures to access 1 million human genomes by 2022 , 2019, Nature Reviews Genetics.
[14] Arcadi Navarro,et al. The European Genome-phenome Archive of human data consented for biomedical research , 2015, Nature Genetics.
[15] A. Levine. Academics are from Mars, humanitarians are from Venus: Finding common ground to improve research during humanitarian emergencies , 2016, Clinical trials.
[16] Anton Nekrutenko,et al. No more business as usual: Agile and effective responses to emerging pathogen threats require open data and open analytics , 2020, bioRxiv.